Entera Bio's total assets for Q1 2025 were $21.60M, an increase of 130.03% from the previous quarter. ENTX total liabilities were $2.22M for the fiscal quarter, a 69.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.